Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)

被引：25

作者：

Guarneri, Valentina ^{[1
]}

Frassoldati, Antonio ^{[1
]}

Piacentini, Federico ^{[1
]}

Jovic, Gordana ^{[1
]}

Giovannelli, Simona ^{[1
]}

Oliva, Cristina ^{[2
]}

Conte, PierFranco ^{[1
]}

机构：

[1] Univ Modena & Reggio Emilia, Univ Hosp, Dept Hematol & Oncol, Div Med Oncol, I-41100 Modena, Italy

[2] GlaxoSmithKline, Oncol Med Dev Ctr, Greenford, Middx, England

来源：

CLINICAL BREAST CANCER | 2008年 / 8卷 / 02期

关键词：

epidermal growth factor receptor; immunohistochemistry; pathologic complete response;

D O I：

10.3816/CBC.2008.n.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：192 / 194

页数：3

共 14 条

[1] Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer [J].

Buzdar, AU ;

Ibrahim, NK ;

Francis, D ;

Booser, DJ ;

Thomas, ES ;

Theriault, RL ;

Pusztai, L ;

Green, MC ;

Arun, BK ;

Giordano, SH ;

Cristofanilli, M ;

Frye, DK ;

Smith, TL ;

Hunt, KK ;

Singletary, SE ;

Sahin, AA ;

Ewer, MS ;

Buchholz, TA ;

Berry, D ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3676-3685

[2]

FINN RS, 2007, 14 EUR CANC C SEPT 2

[3] Lapatinib plus capecitabine for HER2-positive advanced breast cancer [J].

Geyer, Charles E. ;

Forster, John ;

Lindquist, Deborah ;

Chan, Stephen ;

Romieu, C. Gilles ;

Pienkowski, Tadeusz ;

Jagiello-Gruszfeld, Agnieszka ;

Crown, John ;

Chan, Arlene ;

Kaufman, Bella ;

Skarlos, Dimosthenis ;

Campone, Mario ;

Davidson, Neville ;

Berger, Mark ;

Oliva, Cristina ;

Rubin, Stephen D. ;

Stein, Steven ;

Cameron, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26) :2733-2743

[4] Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors [J].

Guarneri, V ;

Broglio, K ;

Kau, SW ;

Cristofanilli, M ;

Buzdar, AU ;

Valero, V ;

Buchholz, T ;

Meric, F ;

Middleton, L ;

Hortobagyi, GN ;

Gonzalez-Angulo, AM .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1037-1044

[5] Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer [J].

Joensuu, H ;

Kellokumpu-Lehtinen, P ;

Bono, P ;

Alanko, T ;

Kataja, V ;

Asola, R ;

Utriainen, T ;

Kokko, R ;

Hemminki, A ;

Tarkkanen, M ;

Turpeenniemi-Hujanen, T ;

Jyrkkiö, S ;

Flander, M ;

Helle, L ;

Ingalsuo, S ;

Johansson, K ;

Jääskeläinen, A ;

Pajunen, M ;

Rauhala, M ;

Kaleva-Kerola, J ;

Salminen, T ;

Leinonen, M ;

Elomaa, I ;

Isola, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :809-820

[6] Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells [J].

Konecny, GE ;

Pegram, MD ;

Venkatesan, N ;

Finn, R ;

Yang, GR ;

Rahmeh, M ;

Untch, M ;

Rusnak, DW ;

Spehar, G ;

Mullin, RJ ;

Keith, BR ;

Gilmer, TM ;

Berger, M ;

Podratz, KC ;

Slamon, DJ .

CANCER RESEARCH, 2006, 66 (03) :1630-1639

[7] HER2 therapy - Molecular mechanisms of trastuzumab resistance [J].

Nahta, Rita ;

Esteva, Francisco J. .

BREAST CANCER RESEARCH, 2006, 8 (06)

[8] Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer [J].

Piccart-Gebhart, MJ ;

Procter, M ;

Leyland-Jones, B ;

Goldhirsch, A ;

Untch, M ;

Smith, I ;

Gianni, L ;

Baselga, J ;

Bell, R ;

Jackisch, C ;

Cameron, D ;

Dowsett, M ;

Barrios, CH ;

Steger, G ;

Huang, CS ;

Andersson, M ;

Inbar, M ;

Lichinitser, M ;

Láng, I ;

Nitz, U ;

Iwata, H ;

Thomssen, C ;

Lohrisch, C ;

Suter, TM ;

Ruschoff, J ;

Süto, T ;

Greatorex, V ;

Ward, C ;

Straehle, C ;

McFadden, E ;

Dolci, MS ;

Gelber, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1659-1672

[9] Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer [J].

Romond, EH ;

Perez, EA ;

Bryant, J ;

Suman, VJ ;

Geyer, CE ;

Davidson, NE ;

Tan-Chiu, E ;

Martino, S ;

Paik, S ;

Kaufman, PA ;

Swain, SM ;

Pisansky, TM ;

Fehrenbacher, L ;

Kutteh, LA ;

Vogel, VG ;

Visscher, DW ;

Yothers, G ;

Jenkins, RB ;

Brown, AM ;

Dakhil, SR ;

Mamounas, EP ;

Lingle, WL ;

Klein, PM ;

Ingle, JN ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1673-1684

[10]

SLAMON D, 2005, 28 ANN SAN ANT BREAS

← 1 2 →